Effect of Weight Loss with Reduction of Intra-Abdominal Fat on Lipid Metabolism in Older Men1
Jonathan Q. Purnell,
Steven E. Kahn,
John J. Albers,
David N. Nevin,
John D. Brunzell and
Robert S. Schwartz
Division of Metabolism, Endocrinology, and Nutrition, Department of
Medicine, University of Washington (J.Q.P., S.E.K., D.N.N., J.D.B.);
Department of Gerontology and Geriatric Medicine, University of
Washington (R.S.S.); and Northwest Lipid Research Laboratories,
University of Washington (J.J.A.), Seattle, Washington 98195
Address all correspondence and requests for reprints to: Jonathan Q. Purnell, M.D., Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Box 359757, Seattle, Washington 98104. E-mail: purnell{at}u.washington.edu
How weight loss improves lipid levels is poorly understood.
Cross-sectionalstudies have suggested that accumulation of fat in
intraabdominalstores (IAF) may lead to abnormal lipid levels,
increased hepaticlipase (HL) activity, and smaller low density
lipoprotein (LDL)particle size. To determine what effect loss of IAF
would haveon lipid parameters, 21 healthy older men underwent
diet-inducedweight loss. During a period of weight stability before
andafter weight loss, subjects underwent studies of body composition,
lipids,measurement of postheparin lipoprotein and HL lipase
activities,cholesteryl ester transfer protein activity, and insulin
sensitivity(Si). After an average weight loss of 10%, reductions in
fatmass, IAF, and abdominal sc fat were seen, accompanied by
reductionsin levels of triglyceride, very low density lipoprotein
cholesterol,apolipoprotein B, and HL activity. High density
lipoprotein-2cholesterol and Si increased. In those subjects with
patternB LDL at baseline, LDL particle size increased. Cholesteryl
estertransfer protein activity did not change. Changes in IAF andSi
correlated with a decrease in HL activity (although not independently
ofeach other). In summary, in men undergoing diet-induced weightloss,
only loss of IAF was found to be associated with a reductionin HL,
which is associated with beneficial effects on lipidlevels.
This article has been cited by other articles:
E. Ferrannini and G. Mingrone Impact of Different Bariatric Surgical Procedures on Insulin Action and {beta}-Cell Function in Type 2 Diabetes
Diabetes Care,
March 1, 2009;
32(3):
514 - 520.
[Full Text][PDF]
P. H. Yovchevski and N. I. Doncheva Low-Dose Statin Concentration in Red Yeast Rice: A Confounding Effect on Outcome?
Mayo Clin. Proc.,
October 1, 2008;
83(10):
1187 - 1187.
[Full Text][PDF]
P. M. Janiszewski, T. J. Saunders, and R. Ross Themed Review: Lifestyle Treatment of the Metabolic Syndrome
American Journal of Lifestyle Medicine,
April 1, 2008;
2(2):
99 - 108.
[Abstract][PDF]
J. D. Brunzell Hypertriglyceridemia
N. Engl. J. Med.,
September 6, 2007;
357(10):
1009 - 1017.
[Full Text][PDF]
B. Buemann, A. Astrup, O. Pedersen, E. Black, C. Holst, S. Toubro, S. Echwald, J. J. Holst, C. Rasmussen, and T. I. A. Sorensen Possible Role of Adiponectin and Insulin Sensitivity in Mediating the Favorable Effects of Lower Body Fat Mass on Blood Lipids
J. Clin. Endocrinol. Metab.,
May 1, 2006;
91(5):
1698 - 1704.
[Abstract][Full Text][PDF]
D. T Villareal, C. M Apovian, R. F Kushner, and S. Klein Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society
Am. J. Clinical Nutrition,
November 1, 2005;
82(5):
923 - 934.
[Abstract][Full Text][PDF]
J. G. Schneider, M. von Eynatten, S. Schiekofer, P. P. Nawroth, and K. A. Dugi Low Plasma Adiponectin Levels Are Associated With Increased Hepatic Lipase Activity In Vivo
Diabetes Care,
September 1, 2005;
28(9):
2181 - 2186.
[Abstract][Full Text][PDF]
I. Giannopoulou, L. L. Ploutz-Snyder, R. Carhart, R. S. Weinstock, B. Fernhall, S. Goulopoulou, and J. A. Kanaley Exercise Is Required for Visceral Fat Loss in Postmenopausal Women with Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
March 1, 2005;
90(3):
1511 - 1518.
[Abstract][Full Text][PDF]
G. F. Lewis, S. Murdoch, K. Uffelman, M. Naples, L. Szeto, A. Albers, K. Adeli, and J. D. Brunzell Hepatic Lipase mRNA, Protein, and Plasma Enzyme Activity Is Increased in the Insulin-Resistant, Fructose-Fed Syrian Golden Hamster and Is Partially Normalized by the Insulin Sensitizer Rosiglitazone
Diabetes,
November 1, 2004;
53(11):
2893 - 2900.
[Abstract][Full Text][PDF]
S. Klein, L. Fontana, V. L. Young, A. R. Coggan, C. Kilo, B. W. Patterson, and B. S. Mohammed Absence of an Effect of Liposuction on Insulin Action and Risk Factors for Coronary Heart Disease
N. Engl. J. Med.,
June 17, 2004;
350(25):
2549 - 2557.
[Abstract][Full Text][PDF]
B. Todorova, A. Kubaszek, J. Pihlajamaki, J. Lindstrom, J. Eriksson, T. T. Valle, H. Hamalainen, P. Ilanne-Parikka, S. Keinanen-Kiukaanniemi, J. Tuomilehto, et al. The G-250A Promoter Polymorphism of the Hepatic Lipase Gene Predicts the Conversion from Impaired Glucose Tolerance to Type 2 Diabetes Mellitus: The Finnish Diabetes Prevention Study
J. Clin. Endocrinol. Metab.,
May 1, 2004;
89(5):
2019 - 2023.
[Abstract][Full Text][PDF]
M. J. Sharman, A. L. Gomez, W. J. Kraemer, and J. S. Volek Very Low-Carbohydrate and Low-Fat Diets Affect Fasting Lipids and Postprandial Lipemia Differently in Overweight Men
J. Nutr.,
April 1, 2004;
134(4):
880 - 885.
[Abstract][Full Text][PDF]
M. Tiikkainen, R. Bergholm, A. Rissanen, A. Aro, I. Salminen, M. Tamminen, K. Teramo, and H. Yki-Jarvinen Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women
Am. J. Clinical Nutrition,
January 1, 2004;
79(1):
22 - 30.
[Abstract][Full Text][PDF]
S. D. Sibley, J. P. Palmer, I. B. Hirsch, and J. D. Brunzell Visceral Obesity, Hepatic Lipase Activity, and Dyslipidemia in Type 1 Diabetes
J. Clin. Endocrinol. Metab.,
July 1, 2003;
88(7):
3379 - 3384.
[Abstract][Full Text][PDF]
S. S. Deeb, A. Zambon, M. C. Carr, A. F. Ayyobi, and J. D. Brunzell Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet
J. Lipid Res.,
July 1, 2003;
44(7):
1279 - 1286.
[Abstract][Full Text][PDF]
N. Landry, N. Bergeron, R. Archer, P. Samson, L. Corneau, J. Bergeron, and O. Deriaz Whole-body fat oxidation rate and plasma triacylglycerol concentrations in men consuming an ad libitum high-carbohydrate or low-carbohydrate diet
Am. J. Clinical Nutrition,
March 1, 2003;
77(3):
580 - 586.
[Abstract][Full Text][PDF]
G. E. Duncan, M. G. Perri, D. W. Theriaque, A. D. Hutson, R. H. Eckel, and P. W. Stacpoole Exercise Training, Without Weight Loss, Increases Insulin Sensitivity and Postheparin Plasma Lipase Activity in Previously Sedentary Adults
Diabetes Care,
March 1, 2003;
26(3):
557 - 562.
[Abstract][Full Text][PDF]
M. Tiikkainen, R. Bergholm, S. Vehkavaara, A. Rissanen, A.-M. Hakkinen, M. Tamminen, K. Teramo, and H. Yki-Jarvinen Effects of Identical Weight Loss on Body Composition and Features of Insulin Resistance in Obese Women With High and Low Liver Fat Content
Diabetes,
March 1, 2003;
52(3):
701 - 707.
[Abstract][Full Text][PDF]
D. J. Nieves, M. Cnop, B. Retzlaff, C. E. Walden, J. D. Brunzell, R. H. Knopp, and S. E. Kahn The Atherogenic Lipoprotein Profile Associated With Obesity and Insulin Resistance Is Largely Attributable to Intra-Abdominal Fat
Diabetes,
January 1, 2003;
52(1):
172 - 179.
[Abstract][Full Text][PDF]
B. A Gower, R. L Weinsier, J. M Jordan, G. R Hunter, and R. Desmond Effects of weight loss on changes in insulin sensitivity and lipid concentrations in premenopausal African American and white women
Am. J. Clinical Nutrition,
November 1, 2002;
76(5):
923 - 927.
[Abstract][Full Text][PDF]
H. Jansen, A. J. M. Verhoeven, and E. J. G. Sijbrands Hepatic lipase: a pro- or anti-atherogenic protein?
J. Lipid Res.,
September 1, 2002;
43(9):
1352 - 1362.
[Abstract][Full Text][PDF]
C.F. Ebenbichler, M. Laimer, S. Kaser, A. Ritsch, A. Sandhofer, H. Weiss, F. Aigner, and J.R. Patsch Relationship Between Cholesteryl Ester Transfer Protein and Atherogenic Lipoprotein Profile in Morbidly Obese Women
Arterioscler Thromb Vasc Biol,
September 1, 2002;
22(9):
1465 - 1469.
[Abstract][Full Text][PDF]
E. T.P. Keulen, M. Kruijshoop, N. C. Schaper, A. P.G. Hoeks, and T. W.A. de Bruin Increased Intima-Media Thickness in Familial Combined Hyperlipidemia Associated With Apolipoprotein B
Arterioscler Thromb Vasc Biol,
February 1, 2002;
22(2):
283 - 288.
[Abstract][Full Text][PDF]
S. E. Kahn, R. L. Prigeon, R. S. Schwartz, W. Y. Fujimoto, R. H. Knopp, J. D. Brunzell, and D. Porte Jr. Obesity, Body Fat Distribution, Insulin Sensitivity and Islet {{beta}}-Cell Function as Explanations for Metabolic Diversity
J. Nutr.,
February 1, 2001;
131(2):
354S - 360.
[Abstract][Full Text]